{"nct_id":"NCT04508023","title":"A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection","status":"TERMINATED","status_verified_date":"2023-07","start_date":"2020-08-13","start_date_type":"ACTUAL","primary_completion_date":"2022-06-01","primary_completion_date_type":"ACTUAL","completion_date":"2022-06-01","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["JNJ"]}